Verrica Pharmaceuticals shares plummet after shocking 3Q results and massive restructuring
Shares of Verrica Pharmaceuticals Inc. faced a sharp decline after the company disclosed disappointing third-quarter 2024 financial results and revealed plans for significant operational restructuring. The biopharmaceutical firm’s stock dropped by 13.29% in after-hours trading, signaling a substantial loss of investor confidence as it closed at $1.24 per share on November 4, 2024. This downturn […]